EPA reaches $4.2M settlement over 2019 explosion and fire at a Philadelphia refinery

Date:

Share post:


PHILADELPHIA — The U.S. Environmental Protection Agency has reached a tentative $4.2 settlement with a firm that owned and operated a major East Coast refinery that was shuttered after an explosion and fire in 2019.

The deal with Philadelphia Energy Solutions was announced Tuesday. There will now be a 30-day public comment period before the settlement plan can be considered for final court approval. The company does not admit to any liability in the settlement, which the EPA said is the largest amount ever sought for a refinery under a Clean Air Act rule that requires owners and operators to ensure that regulated and other extremely hazardous substances are managed safely.

The EPA found that the company failed to identify and assess hazards posed by a pipe elbow in a hydrofluoric acid alkylation unit at the refinery in Philadelphia. The pipe elbow ruptured due to “extensive” corrosion that had withered the pipe wall to the thickness of a credit card since its installation in 1973.

The explosion and subsequent fire on June 21, 2019, eventually forced the refinery to close after being in operation for 150 years. At the time, it was the largest oil refining complex on the East Coast, processing 335,000 barrels of crude oil daily.

The EPA filed the claim in U.S. Bankruptcy Court in Delaware because the company entered bankruptcy shortly after the explosion. The 1,300-acre (526-hectare) site where the refinery had stood was sold in 2020 and is being redeveloped into industrial space and life sciences labs. It remains under a complex cleanup agreement under the oversight of the EPA and Pennsylvania Department of Environmental Protection.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

What's next for EVs under President Trump?

WASHINGTON -- President Donald Trump signed an executive order promising to eliminate what he incorrectly labels “the...

Rosy December for small business sales, but restaurants are left out

NEW YORK -- Small businesses had a merry December, as shoppers wrapped up their holiday shopping.That's according...

Global shares trade mixed in a muted reaction to the U.S. inauguration

TOKYO -- Global shares were mixed in a muted reaction Tuesday to the inauguration of U.S. President...

Sequel to Prince Harry's feud with British tabloids begins in high-stakes trial

LONDON -- The sequel to Prince Harry vs. the British tabloids begins Tuesday in a high-stakes pitting...

Dozens of firms pull ads from Japanese network over sex scandal linked to its staff and celebrity

TOKYO -- Dozens of major Japanese companies have pulled their commercials on Fuji Television amid allegations company...

Canada relieved Trump doesn’t impose tariffs on the major US trading partner on first day

TORONTO -- Canadian leaders expressed relief Monday that broad tariffs were not applied to Canadian products on...

Prada offers savage, instinctive menswear during Milan Fashion Week

MILAN -- MILAN (AP) — Miuccia Prada and her co-creative director Raf Simons described the latest Prada...

Stock market today: Asian shares track Wall St's strong finish ahead of Trump's inauguration

BANGKOK -- Asian shares advanced early Monday after U.S. stock indexes rallied to close out their best...